NCM · Medical - Devices

PLSM (PLSM) Stock

$3.28 -0.91% NCM: PLSM Healthcare

Valuation

MetricValue
Price$3.28
Market Cap$21.33M
P/E Ratio-1.62
P/B Ratio0.31
P/S Ratio1.89
EPS (TTM)$-2.47
52-Week High$10.28
52-Week Low$3.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-19.28%
ROA-15.69%
ROCE-14.46%
Gross Margin-30.00%
Operating Margin-30.00%
Net Margin-39.61%
Debt/Equity0.02
Current Ratio8.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$3.0M$2.0M$3.0M$40.0M
Operating Profit$-7.0M$-13.0M$-15.0M$-12.0M$-12.0M
Net Profit$-8.0M$-6.0M$-16.0M$-10.0M$-16.0M
EPS$-1.61$-1.04$-2.52$-1.57$-2.47
Op Margin-1390.2%-427.2%-898.3%-437.0%-30.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$54.0M$67.0M$50.0M$39.0M$102.0M
Total Liabilities$2.0M$12.0M$11.0M$11.0M$19.0M
Cash$36.0M$4.0M$7.0M$11.0M$22.0M
Borrowings$0$2.0M$2.0M$1.0M$2.0M

Latest News

Pulsenmore Shares Soar After Joining Israel’s Healthcare AI Sandbox Programme (PLSM) InvestorsHub · Jul 13, 2026 Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead a $1 Million AI Development Project PR Newswire · Jul 13, 2026 Pulsenmore Files Resale Registration for 3.1 Million Shares MT Newswires · Jul 2, 2026 Pulsenmore to Raise $7.5 Million in Equity Private Placement MT Newswires · Jun 25, 2026 Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor PR Newswire · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-8.0M$-7.0M$-12.0M$-9.0M$-33.0M
Investing Cash Flow$-14.0M$-88.0M$13.0M$14.0M$14.0M
Financing Cash Flow$1.0M$0$0$0$0
Net Cash Flow$34.0M$-32.0M$2.0M$5.0M$-20.0M
Free Cash Flow$-9.0M$-8.0M$-13.0M$-9.0M$-33.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-43.66%
Quick Ratio7.24
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held43.40%
Institutions Held5.21%
Institutions Float Held9.21%
Institutional HolderSharesReport Date
Aquamarine Financial (cayman) Ltd338,5412026-03-31
UBS Group AG3142026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About PLSM

PLSM is led by CEO Elazar Sonnenschein, employs 58 people, headquartered in IL, publicly traded since 2026.

PLSM stock trades at $3.28 with a market capitalization of $21.33M. The stock is valued at a price-to-earnings (P/E) ratio of -1.62, price-to-book of 0.31, price-to-sales of 1.89. Over the past 52 weeks the stock has ranged between $3.00 and $10.28, and currently trades 68.1% below its 52-week high.

On profitability, PLSM generates a return on equity (ROE) of -19.28%, return on capital employed of -14.46%, an operating margin of -30.00%, a net profit margin of -39.61%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides